PIF1 and cancer: By increasing ROS production, cancer cells and drug resistance can be eliminated, which has been demonstrated by a large number of FDA-approved anticancer drugs [38, 39], while PIF1 is involved in reducing the mitochondrial DNA damage caused by ROS [40].